Success Story: From Poland to NIW Victory! A Chemical Biology Expert Secures Approval in Just Over 1 Month under Premium Processing

Client’s Testimonial:

 

"I am very satisfied with the support I received from Chen Immigration Attorneys throughout my NIW petition process. Their team prepared a highly detailed and well-structured petition that accurately reflected my scientific background, publications, and future research plans. Although the preparation stage required a significant amount of input and documentation on my side, the final petition draft exceeded my expectations and clearly presented the impact and national importance of my work. Communication with the team was consistently professional, organized, and responsive. I especially appreciated their strategic approach and attention to detail during every stage of the process. My NIW petition was approved quickly under premium processing, and I felt confident throughout the entire process knowing my case was in experienced hands. I would highly recommend Chen Immigration Attorneys to researchers and scientists pursuing NIW or other employment-based immigration petitions.”

 


 

On April 24th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Chemical Biology (Approval Notice).

 


 

General Field: Chemical Biology

 

Position at the Time of Case Filing: Postdoctoral Associate

 

Country of Origin: Poland

 

State of Residence at the Time of Filing:  Colorado

 

Approval Notice Date: April 24th, 2026

 

Processing Time: 1 month, 1 day (Premium Processing Requested)

 


 

Case Summary:

 

A postdoctoral associate in the field of chemical biology, pioneering RNA-based biosensor technology for cancer research, secured an EB-2 NIW approval in just over one month under premium processing without an RFE. The client's work centers on engineering modular RNA-based fluorescent biosensors to unlock real-time insights into cellular metabolism, with the ultimate goal of advancing targeted therapies for major diseases, including cancer.

 

Client Background and Proposed Endeavor

 

Holding a Ph.D. in chemical sciences, the client brings deep expertise in RNA-based molecular tool development, nucleic-acid engineering, and bioconjugation chemistry. The proposed endeavor is to continue conducting cutting-edge research in chemical biology, with a focus on developing advanced molecular sensing tools to improve the understanding of disease-related biological processes and support the advancement of targeted therapies.

 

National Significance of the Research

 

We emphasized that this research has far-reaching implications for the United States. The client's work advances early disease detection and biomarker discovery, supports foundational basic research to better characterize the biological changes that initiate and drive cancer development, and falls within federally identified critical and emerging technology areas recognized as vital to U.S. national security and technological leadership. Notably, the client's research has been supported with funding from the National Institutes of Health (NIH) and the National Science Foundation (NSF), underscoring its alignment with federally prioritized biomedical research.

 

Impressive Credentials and Achievements

 

To further strengthen the case, we highlighted exceptional credentials:

 

  • Publications: An impressive portfolio of 23 peer-reviewed journal articles (7 first-authored), 10 first-authored abstracts, and 1 first-authored book chapter.
  • Citations: The work has been cited 849 times
  • Peer Review: The client has completed at least 17 peer reviews.

 

Case Outcome

 

Considering the strength of these accomplishments, this NIW petition earned swift approval without an RFE. It has been an honor to support the client throughout this journey, and we extend our sincere best wishes for continued success.